Tajinderpal Saraon is a Cardiology physician affiliated with NYU Langone Health. OpenAlex indexes 52 publications with 402 citations (h-index 8); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Brachial Right Ventricle - Endomyocardial Biopsy
Sponsor: NYU Langone Health
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
8 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
75.5%Angiotensin receptor-neprilysin inhibitor (ARNI)20.1%Entresto100%Part D≥36 patientsBeta blocker14.1%Metoprolol Succinate73%Carvedilol27%Part D≥28 patients+ 7 more classes in this area
Blood & clotting
11%Factor Xa inhibitor9%Eliquis67%Xarelto33%Part D<11 patientsP2Y12 inhibitor2%Clopidogrel100%Part D<11 patientsMetabolism & gastrointestinal
10.8%SGLT2 inhibitor8.6%Jardiance71%Farxiga29%Part D<11 patientsProton pump inhibitor2.2%Pantoprazole Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- P26. Molecular Signatures of Heart Transplant Rejection from Histologically Normal Biopsies
Journal of Thoracic and Cardiovascular Surgery
2026 - Alpha-Gal-KO Xenothymokidney Function in a Living Human Recipient with a Durable Mechanical Circulatory Support Device
American Journal of Transplantation
2025 - Successful Provision of Advanced Cardiac Therapies in an Urban Safety Net Hospital: Model for Improving Access and Equity
The Journal of Heart and Lung Transplantation
2025 - The Renin-Angiotensin-Aldosterone Axis in a Living Human Recipient with Porcine Xenothymokidney and Intact Native Kidneys
American Journal of Transplantation
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Gareth Morgan, MD
NYU Langone Health
Nathan Levin, MD
NYU Langone Health
Ira Jacobson, MD
NYU Langone Health
Michael Zelefsky, MD
NYU Langone Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”